Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, presenting promising developments across a variety of clinical and industrial purposes. With its structural similarity to By natural means derived human serum albumin, OsrHSA supplies a safer, much more dependable alternate for ther